Witjes JA - Search Results

1

EAU guidelines on primary urethral carcinoma.

Gakis G, Witjes JA, Compérat E, Cowan NC, De Santis M, Lebret T, Ribal MJ, Sherif AM; European Association of Urology. Gakis G, et al. Among authors: witjes ja. Eur Urol. 2013 Nov;64(5):823-30. doi: 10.1016/j.eururo.2013.03.044. Epub 2013 Apr 2. Eur Urol. 2013. PMID: 23582479 Review.

2

Treatment of carcinoma in situ of the urethra with intraurethral instillations of bacillus Calmette-Guérin. Case report and review of literature.

Witjes JA, Debruyne FM, van der Meijden AP. Witjes JA, et al. Eur Urol. 1991;20(2):170-2. doi: 10.1159/000471691. Eur Urol. 1991. PMID: 1752279 Review.

3

Extramedullary plasmacytoma of the urethra: a case report.

Witjes JA, De Vries JD, Schaafsma HE, Bogman MJ, Barentsz JO, Corten RL. Witjes JA, et al. J Urol. 1991 Apr;145(4):826-8. doi: 10.1016/s0022-5347(17)38464-1. J Urol. 1991. PMID: 2005709

4

Risk factors in carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.

van Gils-Gielen RJ, Witjes WP, Caris CT, Debruyne FM, Witjes JA, Oosterhof GO. van Gils-Gielen RJ, et al. Among authors: witjes wp, witjes ja. Urology. 1995 Apr;45(4):581-6. doi: 10.1016/s0090-4295(99)80047-8. Urology. 1995. PMID: 7716838 Clinical Trial.

5

Treatment of carcinoma in situ of the urinary bladder with bropirimine.

Witjes JA. Witjes JA. Eur Urol. 1997;31 Suppl 1:27-30. doi: 10.1159/000474528. Eur Urol. 1997. PMID: 9076483 Review.

6

Toxicity and results of MVAC (methotrexate, vinblastine, adriamycin and cisplatin) chemotherapy in advanced urothelial carcinoma.

Witjes JA, Wullink M, Oosterhof GO, de Mulder P. Witjes JA, et al. Eur Urol. 1997;31(4):414-9. doi: 10.1159/000474499. Eur Urol. 1997. PMID: 9187900 Clinical Trial.

7

The prognostic value of a primary inverted papilloma of the urinary tract.

Witjes JA, van Balken MR, van de Kaa CA. Witjes JA, et al. J Urol. 1997 Oct;158(4):1500-5. J Urol. 1997. PMID: 9302151 Free article. Review.

8

Presence of carcinoma in situ and high 2C-deviation index are the best predictors of invasive transitional cell carcinoma of the bladder in patients with high-risk Quanticyt.

van Rhijn BW, van der Poel HG, Boon ME, Debruyne FM, Schalken JA, Witjes JA. van Rhijn BW, et al. Among authors: witjes ja. Urology. 2000 Mar;55(3):363-7. doi: 10.1016/s0090-4295(99)00460-4. Urology. 2000. PMID: 10699611

9

Bladder carcinoma in situ in 2003: state of the art.

Witjes JA. Witjes JA. Eur Urol. 2004 Feb;45(2):142-6. doi: 10.1016/j.eururo.2003.09.013. Eur Urol. 2004. PMID: 14733997 Review.

10

Preliminary European results of local microwave hyperthermia and chemotherapy treatment in intermediate or high risk superficial transitional cell carcinoma of the bladder.

van der Heijden AG, Kiemeney LA, Gofrit ON, Nativ O, Sidi A, Leib Z, Colombo R, Naspro R, Pavone M, Baniel J, Hasner F, Witjes JA. van der Heijden AG, et al. Among authors: witjes ja. Eur Urol. 2004 Jul;46(1):65-71; discussion 71-2. doi: 10.1016/j.eururo.2004.01.019. Eur Urol. 2004. PMID: 15183549

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

507 results

Search Page